Alan Y Wang

US Patent:

8507722, Aug 13, 2013

Filed:

Aug 29, 2012

Appl. No.:

13/597381

Inventors:

Alan Xiangdong Wang - Wallingford CT, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 215/38

US Classification:

562874

Abstract:

Hepatitis C virus inhibitors are disclosed having the general formula:.

US Patent:

20210395262, Dec 23, 2021

Filed:

Oct 22, 2019

Appl. No.:

17/284816

Inventors:

- Brentford, Middlesex, GB
Kyle E. PARCELLA - Branford CT, US
Manoj PATEL - Branford CT, US
Christiana IWUAGWU - Branford CT, US
Michael S. BOWSHER - Branford CT, US
Alan Xiangdong WANG - Wallingford CT, US

International Classification:

C07D 491/107
C07D 403/14
C07D 413/14
C07D 498/18
C07D 417/14
C07D 498/08
A61K 45/06

Abstract:

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

US Patent:

20210399767, Dec 23, 2021

Filed:

Aug 26, 2021

Appl. No.:

17/412501

Inventors:

- Irvine CA, US
Maryam ROFOUGARAN - Rancho Palos Verdes CA, US
Sam GHARAVI - Irvine CA, US
Qiyue "Jack" ZOU - Elk Grove CA, US
Alan WANG - Irvine CA, US
Farid SHIRINFAR - Granada Hills CA, US
Mike BOERS - South Turramurra, AU

International Classification:

H04B 7/015
H04B 7/155
H04W 76/15
H04W 24/10
H04B 17/318
H04W 72/04

Abstract:

A communication device includes a donor receiver that receives a plurality of first beam of input radio frequency (RF) signals. The communication device further includes a service transmitter that transmits a plurality of second beam of RF signals in a first radiation pattern to a user equipment (UE). The communication device further includes control circuitry that detects an amount and a direction of reflected RF signals at the donor receiver. The control circuitry applies polarization to the plurality of second beam of RF signals and calibrates the polarization to minimize the reflected RF signals at the donor receiver. A second radiation pattern is generated for the plurality of second beam of RF signals and communicated to the UE based on the calibrated polarization.

US Patent:

20210024503, Jan 28, 2021

Filed:

Apr 11, 2019

Appl. No.:

17/042413

Inventors:

- Brentford, Middlesex, GB
John A. BENDER - Wallingford CT, US
David B. FRENNESSON - Wallingford CT, US
Eric P. GILLIS - Branford CT, US
Christiana IWUAGWU - Branford CT, US
John F. KADOW - Branford CT, US
B. Narasimhulu NAIDU - Branford CT, US
Kyle E. PARCELLA - Branford CT, US
Kevin M. PEESE - Branford CT, US
Ramkumar RAJAMANI - Wallingford CT, US
Mark G. SAULNIER - Wallingford CT, US
Alan Xiangdong WANG - Wallingford CT, US
Manoj PATEL - Branford CT, US
Michael S. BOWSHER - Branford CT, US

International Classification:

C07D 403/14
A61P 31/18
C07D 403/12
C07D 401/14
C07D 405/14
C07D 413/14
C07D 491/052

Abstract:

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

US Patent:

20200099418, Mar 26, 2020

Filed:

Apr 29, 2019

Appl. No.:

16/398195

Inventors:

- Newport Beach CA, US
Maryam Rofougaran - Rancho Palos Verdes CA, US
Sam Gharavi - Irvine CA, US
Qiyue "Jack" Zou - Elk Grove CA, US
Alan Wang - Irvine CA, US
Farid Shirinfar - Granada Hills CA, US
Mike Boers - South Turramurra, AU

International Classification:

H04B 7/015
H04B 7/155
H04W 72/04
H04W 24/10
H04B 17/318
H04W 76/15

Abstract:

A communication device includes a donor receiver that receives a first beam of input radio frequency (RF) signals from a base station or a network node. The communication device further includes a service transmitter that transmits a second beam of RF signals in a first radiation pattern to a user equipment (UE). The communication device further includes control circuitry that detects an amount and a direction of echo signals at the donor receiver. The control circuitry applies polarization to the second beam of RF signals transmitted to the UE and calibrates the polarization to minimize the echo signals at the donor receiver. A second radiation pattern is generated for the second beam of RF signals and communicated to the UE based on the calibrated polarization. The communication of the second beam of RF signals in the generated second radiation pattern further reduces the echo signals at the donor receiver.

US Patent:

20180086697, Mar 29, 2018

Filed:

Apr 22, 2016

Appl. No.:

15/565690

Inventors:

- Brentford, GB
Robert G. GENTLES - Wallingford CT, US
Annapurna PENDRI - Wallingford CT, US
Alan Xiangdong WANG - Wallingford CT, US
Nicholas A. MEANWELL - Wallingford CT, US
Brett R. BENO - Wallingford CT, US
Robert A. FRIDELL - Wallingford CT, US
Makonen BELEMA - Wallingford CT, US
Van N. NGUYEN - Auburn MI, US
Zhong YANG - Southington CT, US
Gan WANG - Cheshire CT, US
Selvakumar KUMARAVEL - Bangalore IN, US
Rajesh Onkardas BORA - Bangalore IN, US
Mallikarjuna Rao METTU - Bangalore IN, US
Manoranjan PANDA - Bangalore IN, US

International Classification:

C07C 307/06
C07C 307/10
C07C 311/08
A61P 31/18

Abstract:

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

US Patent:

20180072997, Mar 15, 2018

Filed:

Apr 22, 2016

Appl. No.:

15/565716

Inventors:

- Brentford, Middlesex, GB
Omar D. LOPEZ - Wallingford CT, US
Van N. NGUYEN - Auburn MI, US
Zhong YANG - Southington CT, US
Alan Xiangdong WANG - Wallingford CT, US
Gan WANG - Cheshire CT, US
Nicholas A. MEANWELL - Wallingford CT, US
Brett R. BENO - Wallingford CT, US
Robert A. FRIDELL - Wallingford CT, US
Makonen BELEMA - Wallingford CT, US
Srinivasan THANGATHIRUPATHY - Bangalore, Karnataka, IN

International Classification:

C12N 7/06
C07C 237/22
C07C 271/22
C07C 275/24
C07C 307/06
C07C 311/06
C07C 311/19
C07D 213/61
C07D 235/26
C07D 271/12
C07D 277/62
C07D 285/14
C07D 295/192
C07D 317/66
C07K 5/02

Abstract:

Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below:

US Patent:

20160257645, Sep 8, 2016

Filed:

Oct 23, 2014

Appl. No.:

15/031352

Inventors:

- Princeton NJ, US
Guo Li - Wallingford CT, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Alan Xiangdong Wang - Wallingford CT, US
Brett R. Beno - Cromwell CT, US
Robert A. Fridell - Guilford CT, US
Makonen Belema - North Haven CT, US
Nicholas A. Meanwell - East Hampton CT, US
Robert G. Gentles - Killingworth CT, US

International Classification:

C07C 311/58
C07D 317/66
C07D 409/12
C07D 405/12
C07D 317/46
C07D 407/12
C07D 271/06
C07D 307/38
C07D 333/18
C07D 231/12
C07D 333/54
C07D 209/10
C07D 333/28
C07D 261/08
C07D 215/08
C07D 209/08
C07D 277/82
C07D 495/04
C07D 491/08
C07D 205/04
C07D 401/04
C07D 213/56
C07D 249/08
C07D 265/36

Abstract:

Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth: Formula: (I)